EXPAMER
Juno Therapeutics, Inc.
Mark For: EXPAMER® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79164309 |
| Registration Number | 4929639 |
| Mark Literal Elements | EXPAMER |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK. SERVICE MARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2016-04-05 |
| Basis | 66(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | Yes |
| Current Basis | No |
| No Basis | No |
| Domestic Representative | Jennifer Lee Taylor |
| Attorney Name | Camille M. Miller |
| Law Office Assigned | M30 |
| Employee Name | MARTIN, LIEF ANDREW |
Timeline
| 2015-02-09 | Application Filed |
| 2016-01-19 | Published |
| 2016-01-19 | Published for Opposition |
| 2016-04-05 | Location: PUBLICATION AND ISSUE SECTION |
| 2016-04-05 | Status: Live/Registered |
| 2016-04-05 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2016-04-05 | Trademark Registered |
| 2018-07-08 | Transaction Date |
| 2022-04-05 | Maintenance On Time Date |
| 2022-10-05 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  Juno Therapeutics, Inc. |
| Address | 400 Dexter Avenue North, Suite 1200 Seattle WA 98109 UNITED STATES |
| Legal Entity Type | Gmbh |
| Legal Entity State | GERMANY |
Documents
Application
DrawingAttorney of Record
Good, Services, and Codes
IC 001. US 001 005 006 010 026 046. G & S: Chemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; chemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of T cells or B cells; kits containing chemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; kits containing chemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of T cells or B cells
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical and veterinary preparations, in particular cells, in particular body cells and cells of the immune system of mammals including human cells; stimulated and/or expanded T cells or B cells for medical purposes
IC 009. US 021 023 026 036 038. G & S: Scientific apparatus for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; scientific apparatus for the stimulation and/or expansion of T cells or B cells
IC 042. US 100 101. G & S: Scientific and industrial research in the field of biochemistry, diagnostics or pharmaceuticals; services of a biochemical or pharmaceutical laboratory, in particular stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; stimulation and/or expansion of t cells or b cells for scientific and industrial research purposes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 9 |
| U.S. Codes: | 021,023,026,036,038 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0011 | Chemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; chemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of T cells or B cells; kits containing chemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of cells, in particular of cells of the immune system of mammals including human cells; kits containing chemical reagents, for scientific and research use and for use in biotechnological manufacturing processes, for the stimulation and/or expansion of T cells or B cells |
Assignments
| Description | Date |
|---|---|
 Trademark Assignment 6201-0886 [2 Pages] | 2017-12-07 |
| Trademark Assignment 5596-0260 [2 Pages] | 2015-08-13 |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | 2021-04-05 | |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-04-02 | |
| NEW REPRESENTATIVE AT IB RECEIVED | 2020-04-09 | |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-03-30 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-03-30 | |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2017-12-07 | |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2016-07-29 | |
| FINAL DISPOSITION PROCESSED | 2016-07-07 | 72629 |
| FINAL DISPOSITION NOTICE SENT TO IB | 2016-07-07 | |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2016-07-05 | |
| REGISTERED-PRINCIPAL REGISTER | 2016-04-05 | |
| NOTIFICATION PROCESSED BY IB | 2016-01-22 | |
| PUBLISHED FOR OPPOSITION | 2016-01-19 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2016-01-19 | |
| NEW REPRESENTATIVE AT IB RECEIVED | 2016-01-07 | |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2015-12-30 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2015-12-30 | |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2015-12-30 | |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2015-12-17 | 77976 |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2015-12-15 | 6328 |
| EXAMINERS AMENDMENT E-MAILED | 2015-12-15 | 6328 |
| EXAMINERS AMENDMENT -WRITTEN | 2015-12-15 | 85328 |
| EXAMINER'S AMENDMENT ENTERED | 2015-12-15 | 88888 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2015-12-15 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2015-12-14 | 77976 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2015-12-14 | 77976 |
| ASSIGNED TO LIE | 2015-12-07 | 77976 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2015-11-18 | |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2015-11-17 | |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2015-11-17 | |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2015-08-13 | |
| REFUSAL PROCESSED BY IB | 2015-06-07 | |
| REFUSAL PROCESSED BY MPU | 2015-05-18 | 72629 |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2015-05-18 | |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2015-05-16 | |
| NON-FINAL ACTION WRITTEN | 2015-05-15 | 85328 |
| ASSIGNED TO EXAMINER | 2015-05-15 | 85328 |
| APPLICATION FILING RECEIPT MAILED | 2015-05-06 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2015-05-02 | |
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2015-04-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 